Affordable Access

Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.

Authors
  • Papayianni, Aikaterini
  • Alexopoulos, Efstathios
  • Giamalis, Panagiotis
  • Gionanlis, Lazaros
  • Belechri, Anna-Maria
  • Koukoudis, Paraschos
  • Memmos, Dimitrios
Type
Published Article
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication Date
Mar 01, 2002
Volume
17
Issue
3
Pages
435–441
Identifiers
PMID: 11865089
Source
Medline
License
Unknown

Abstract

Serum levels of ICAM-1, VCAM-1, and MCP-1 are increased in HD patients and probably result from either inadequate clearance or enhanced synthesis and release. HD session resulted in a significant increase of the above molecule levels but the exact mechanism(s) responsible for these alterations are yet to be fully elucidated. Increased levels of adhesion molecules are associated with inflammation, dyslipidaemia, and cardiovascular events. However, the potential link between these processes and its clinical significance warrants further investigation.

Report this publication

Statistics

Seen <100 times